imgimg
imgimg
img
img
imgimg
Home
Public Policy Institute
About Public Policy Institute
Research Areas
img
Featured Work
Latest News
Publications Archive
img
Event Highlights
img
Academy of Chinese Studies
Hong Kong Chronicles Institute
Media Centre
About Us
About Our Hong Kong Foundation
img
Benefactors
img
Our Governance
Our Hong Kong Foundation
img
Academy of Chinese Studies
img
Hong Kong Chronicles Institute
img
Advisory Members
img
The Management
Legal and Audit
Annual Reports
Careers
Contact Us
Donate Now
imgimgimgimgimgimgimg
Banner
NEWS & STORIES

OHKF Deputy Research Director Victor Kwok Invited as Moderator for Roundtable Discussion on Advancing Innovative Medicines

21 May 2026 (Thu)

Victor Kwok, Deputy Research Director of Our Hong Kong Foundation (OHKF), was invited to attend and moderate the “Roundtable Discussion on Advancing Innovative Medicines,” co-organised by the Cancer Patient Alliance and 長期病患者關注醫療改革聯席 on 2 May.

Guests of the roundtable discussion included Assistant Director of Health (Preparatory Office for Centre for Medical Products Regulation) of Department of Health Chan Sze-Tao, Lot, Director (Cluster Services) of the Hospital Authority Dr Wong Yiu-chung; Member of the Legislative Council Dr Hon Chan Han-pan, BBS, JP; academic experts; and representatives from pharmaceutical companies.

The meeting focused on Hong Kong's performance in developing healthcare innovation and recommendations for further improvements to the current mechanisms for approving and registering innovative drugs, as well as strengthening support for local clinical research and drug development.


Last Updated 15 Jul 2026 (Wed)

Victor Kwok, Deputy Research Director of Our Hong Kong Foundation (OHKF), was invited to attend and moderate the “Roundtable Discussion on Advancing Innovative Medicines,” co-organised by the Cancer Patient Alliance and 長期病患者關注醫療改革聯席 on 2 May.

Guests of the roundtable discussion included Assistant Director of Health (Preparatory Office for Centre for Medical Products Regulation) of Department of Health Chan Sze-Tao, Lot, Director (Cluster Services) of the Hospital Authority Dr Wong Yiu-chung; Member of the Legislative Council Dr Hon Chan Han-pan, BBS, JP; academic experts; and representatives from pharmaceutical companies.

The meeting focused on Hong Kong's performance in developing healthcare innovation and recommendations for further improvements to the current mechanisms for approving and registering innovative drugs, as well as strengthening support for local clinical research and drug development.

Last Updated 15 Jul 2026 (Wed)
Support Us
Donate Now
Contact us
img
19/F Nan Fung Tower, 88 Connaught Road Central, Hong Kong
img
+852 2603 3001
Follow us on
imgimgimgimg
imgimgimg
ESG Care Organization
© Our Hong Kong Foundation Limited. All Rights Reserved.
Support Us
Donate Now
Contact us
19/F Nan Fung Tower, 88 Connaught Road Central, Hong Kong
Follow us on
imgimgimgimg
imgimgimg
ESG

© Our Hong Kong Foundation Limited. All Rights Reserved.